3rd DCT, HYBRID & CENTRALISED CLINICAL TRIALS WORLD CONGRESS 2027 EUROPE
Where Innovation, Collaboration and Human‑Centred Design Meet to Transform Clinical Research
Millennium Hotel and Conference Centre Gloucester London, UK
Day 1 - Thursday 25th February 2027
Strategy, Regulation & Patient‐Centric Transformation
- Integrating decentralised, hybrid and centralised approaches into a cohesive future‐ready ecosystem.
- Regulatory expectations that influence digital trial design, remote data capture, and the operational frameworks required for compliance.
- Patient‐driven priorities that shape protocol flexibility, technology usability, and the overall experience of participating in digitally‐enabled trials.
- Collaboration models that allow pharma, CROs, tech providers and regulators to accelerate modernisation.
Moderator:
Panellists:
- Reviewing evolving guidance on digital consent, telemedicine and remote monitoring.
- Navigating cross‐border compliance challenges in multinational decentralised trials.
- Assessing regulator perspectives on patient‐generated data and digital endpoints.
- Outlining future frameworks that will shape digital trial innovation.
- Determining when decentralisation adds value versus when centralisation is essential.
- Evaluating digital tools across therapeutic areas for measurable operational gains.
- Considering budgeting, ROI and resource allocation for digital transformation.
- Building internal capabilities to support scalable hybrid trial execution.
- Redesigning workflows to support seamless coordination between remote and on‐site activities.
- Staff training frameworks that build confidence in digital tools and ensure consistent execution across sites.
- Addressing multi‐vendor complexity and the operational challenges associated with fragmented technology.
- Maintaining data quality and protocol adherence across decentralised modalities and diverse patient environments.
- Streamlining data flows across eCOA, eConsent, wearables and telemedicine.
- Reducing site burden through automation and integrated workflows.
- Real‐time monitoring tools that enhance operational visibility, enabling proactive issue resolution and improved trial predictability.
- Vendor collaboration models that support scalability, reduce fragmentation and strengthen long‐term digital infrastructure.
- Exploring design principles that ensure digital platforms are intuitive, accessible and inclusive
- Improving adherence through personalised digital engagement.
- Simplifying remote procedures to reduce patient burden enabling high‐quality data capture and safety oversight.
- How patient‐centric digital tools improve recruitment outcomes and broaden access to diverse populations?
- Comparative outcomes from decentralised versus traditional trial designs
- Managing methodological challenges associated with analysing patient‐generated data
- Impact of consumer‐grade devices on data consistency and the implications for endpoint validation.
- Future research standards that strengthen scientific rigour in decentralised methodologies.
- National digital health frameworks that support remote trial participation and enable secure data exchange.
- Public‐private partnerships that accelerate decentralised research and expand access to digital tools.
- Ethical considerations related to remote data collection, privacy protection and equitable access.
- Strategies to build public trust in digital clinical research through transparency and community engagement.
- Identifying digital literacy gaps across patient communities and strategies to support individuals with limited technology experience.
- Co‐designing protocols with patient groups for more practical, usable and inclusive trial experiences.
- Exploring accessibility considerations for rare disease, mobility‐limited and geographically remote patients.
- Approaches that strengthen trust and empower patients throughout digitally‐enabled participation.
4:30 pm - Harnessing AI‐Enabled Safety Monitoring to Improve Remote Oversight and Patient Protection
- Predictive analytics tools that identify emerging safety signals earlier and support proactive intervention strategies.
- Automated remote assessment workflows to reduce manual burden and improve consistency in safety monitoring.
- Integrating AI outputs into regulatory‐compliant processes without compromising oversight or data integrity.
- Patient‐experience improvements enabled by timely, personalised safety interventions
- How sites balance remote responsibilities with traditional on‐site activities while maintaining operational efficiency.
- Addressing technology overload and presenting strategies for platform consolidation that reduce complexity.
- Digital competency programmes that equip site staff with the skills needed to manage modern trial technologies.
- Best practices for maintaining high‐quality data capture and patient engagement in hybrid environments.
- Combining regulatory evolution, hybrid strategy and patient priorities into a unified direction for digital trials.
- Integrating interoperability, technology consolidation and site readiness to strengthen operational foundations.
- Translating academic evidence and public‐sector initiatives into practical frameworks for scalable decentralised research.
- Building long‐term alignment across sponsors, CROs, tech providers, patients and regulators to support sustainable transformation.
Moderator:
Panellists:
Co-located with the 10th Patient Centricity & Collaboration World Congress 2027 Europe.
Joint Networking & Exhibit Area.
